Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 8597946

    Enhanced dendritic cells for cancer immunotherapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8597883

    Biomarkers for cancer-related fatigue and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8598333

    SiRNA silencing of genes expressed in cancer

    Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8592464

    Nitric oxide furoxan derivative compounds endowed with antitumoral activity

    HUMANITAS MIRASOLE S.P.A. · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8586553

    Therapies for cancer using RLIP76

    The Board of Regents of the University of Texas System · Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8575121

    Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8575170

    Flurbiprofen analogs and methods of use in treating cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8568977

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8563595

    Treatment of cancer with complex organic-inorganic pigment compositions

    The Board of Regents of the University of Texas System · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8562944

    PAA nanoparticles for enhancement of tumor imaging

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8563692

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8557245

    Methods for treating bone cancer by administering a nerve growth factor antagonist antibody

    Regents of the University of Minnesota · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8552167

    Multifunctional aptamer-nucleic acid nanostructures for tumor-targeted killing

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8546433

    Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8536132

    Lymphatic zip codes in tumors and pre-malignant lesions

    The Regents of the University of California · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8535639

    Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8535667

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8524248

    Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8524456

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8518647

    Method of diagnosing poor survival prognosis colon cancer using miR-16b

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8518887

    Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8518870

    Compositions and methods for cancer treatment using targeted carbon nanotubes

    The Board of Regents of the University of Oklahoma · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8507445

    Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer

    The Board of Regents of the University of Texas System · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8507012

    Formulations comprising extracts from primitive plant species (mosses, ferns and lichens) to treat and prevent cancers

    Southern Connecticut State University · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8507195

    MiRNAs dysregulated in triple-negative breast cancer

    The Regents of the University of Colorado · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8506947

    Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8501404

    Gnaq mutations in melanoma

    The Regents of the University of California · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8501957

    Benzimidazole compounds and their use as anticancer agents

    China Medical University · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8501912

    Filipil compositions and methods for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8501953

    PKM2 modulators for use in the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. EP 2620148

    Antitumorkombination mit Cabazitaxel und Cisplatin

    AVENTIS PHARMA SA [FR] · Granted Wed Jul 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jul 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8492345

    Cyclic peptide antitumor agents

    Northwestern University · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8486965

    Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8486391

    Cancer treatment kits using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8481760

    Inhibition and treatment of prostate cancer metastasis

    Northwestern University · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8481529

    Combination cancer chemotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8481038

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8470888

    Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8470326

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8465743

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8465917

    Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8450062

    SOCS-3 promoter methylation in cancer

    The Regents of the University of California · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8445507

    Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

    The Regents of the University of California · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8440393

    Pro-angiogenic genes in ovarian tumor endothelial cell isolates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8440692

    Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents

    China Medical University · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8435993

    Methods of inhibiting metastasis from cancer

    Alliance Discovery, Inc. · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8435979

    Use of imipramine blue and analogs thereof in treating cancers

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8435575

    Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

    Aphios Corporation · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.